So your client just went to an Ayahuasca retreat:
What Therapists Need to Know About Plant Medicine
A note before you dive in: this piece is written for clinicians and mental health professionals. It isn't guidance for someone deciding whether to try plant medicine themselves, and nothing here is legal or medical advice for a specific situation.
A few years ago, I would hear the occasional curiosity about an ayahuasca retreat someone had heard of, or a celebrity telling Terry Gross it changed their life, but it felt pretty separate from the psychotherapy world. Something has shifted in more recent years. A neighbor having a Kambo session in Chelsea. A client starting to microdose on psilocybin. Now it's not uncommon for clients to go on retreats near and far and come back wanting to integrate what they learned in these alternative healing spaces.
Sometimes a client will talk about it in therapy before they decide to participate. Generally I stay neutral, helping them talk through their choice and their feelings about it. I have on occasion recommended they speak to someone more knowledgeable in the space before taking the leap. A few times I've recommended against it when we were early in treatment and just beginning to uncover a long history of trauma, not because I have a judgment about these practices, but because I felt cautious about clients who were in unstable places in their life, practically or psychically. The effects of trauma can be long and varied, and can include extreme compartmentalization, derealization, dissociation, and suppression. These defensive strategies may need to stay in place as we slowly work through what happened, and there's less control over what becomes figural when you introduce these powerful medicines.
Most often, a client doesn't need help deciding whether or not to participate but rather wants support integrating what they experienced or learned about themselves into a larger frame. While therapists don't need to know about all forms of healing, I do think it's helpful to understand the basics.
In my experience, finding knowledgeable plant medicine facilitators and coaches who are trauma-informed can be a great source of information and guidance. While I never recommend these types of methods directly to clients (see note about legality and because these are clearly out of my scope of practice) I do have trusted referrals for these alternative healing methods, either for consultation or to share with clients who might need more integration support after the fact than I can provide.
This piece is for clinicians who are seeing this more and more and want a working framework, not a position paper on whether psychedelics are good or bad. That debate exists elsewhere. What we need is clinical competence.
What we're talking about
"Plant medicine" usually refers to ayahuasca, a brew made from Amazonian plants containing DMT, traditionally used in Indigenous ceremonial contexts across South America. "Psilocybin" refers to the compound in certain mushrooms, now legal for supervised use in Oregon and Colorado, and increasingly available through underground facilitators, retreat centers abroad, and a growing body of clinical trials for depression and end-of-life distress.
Two others are showing up in client stories often enough to name specifically. Kambo comes from the secretion of a South American tree frog, applied to small burns on the skin in a ceremonial purging practice. It isn't psychedelic. Clients tend to describe it in terms of intense physical purging and a sense of resetting the body, and it carries real physiological risk that has nothing to do with altered states. Bufo, or 5-MeO-DMT, comes from a different toad's secretion and is smoked. It's short-acting but extremely intense, sometimes described by clients as the most overwhelming experience of their life in the span of fifteen minutes. Both come up less in mainstream coverage than ayahuasca or psilocybin, which can mean clients feel less prepared going in and less able to find good information about what they experienced afterward.
It's worth naming plainly that legal status varies a great deal, and it's changing fast. Psilocybin is legal in supervised, licensed settings in Oregon, Colorado, and now New Mexico, though it remains federally Schedule I everywhere. Ayahuasca and DMT are federally illegal outside a small number of religious exemptions, so most ceremonies clients attend, whether local or on retreat abroad, sit outside any US legal framework. Bufo is federally Schedule I as well. Kambo isn't a scheduled substance in the same way, so it occupies a different legal category, even though it carries its own physical risks. This isn't legal advice, and it's worth checking current status before leaning on any of it for a specific client.
Clients are encountering these substances through very different doors: a licensed Oregon facilitator following a structured protocol, a retreat center in Costa Rica with unclear oversight, or a friend of a friend running ceremonies in an apartment. The setting matters enormously for what kind of experience someone had and what kind of support they need afterward. Part of our job is helping clients tell us which door they walked through, without assuming any of it was reckless or any of it was safe.
It's worth resisting the assumption that underground automatically means careless. A 2018 NYU study that interviewed underground plant medicine facilitators directly found that many of them drew a sharp distinction between their work and recreational drug use, describing their role as centered on safety, intention, and helping people integrate what came up, closer in spirit to what happens in clinical research settings than to recreational use. That doesn't mean oversight is consistent. It varies enormously from one facilitator to the next. But it's a reminder that the label "underground" doesn't tell you much on its own.
Why this is landing in our offices
The people drawn to these experiences often look like our caseload already. High-achieving clients who've exhausted what talk therapy alone could offer. People with complex trauma who've read that psychedelics can access material that feels otherwise locked away. Grieving clients looking for a felt sense of connection that grief groups haven't given them. What they need from us is usually the same thing: somewhere to bring what surfaced.
The integration gap
Retreats can be strong on the experience and thin on what comes after (not all but some). Someone might get an hour of group sharing the next morning and then a plane ticket home. The insight that felt like bedrock at 3 am in the jungle starts to blur by the second week back at work. This is the gap therapists are actually being asked to fill, whether or not we signed up for it.
Integration work isn't about relitigating the trip beat by beat. It's the same work we already do: helping someone build a coherent narrative, make meaning, and translate insight into behavior change, except the raw material is a nonordinary state of consciousness instead of a memory or a pattern noticed in session. Some of what this can look like:
Helping a client separate the emotional truth of an experience from its literal content, especially when the imagery was strange or the client is embarrassed by it
Slowing down a client who wants to overhaul their entire life in the first week back, before the insight has had time to settle
Doing the somatic work to metabolize what surfaced, since these experiences often move material that doesn't stay contained in language
Naming when what looks like integration is actually avoidance, a way of staying in the glow of the experience instead of doing the harder work it pointed toward
What you don't need
You don't need to have done it yourself. You don't need a position on legalization. You don't need to become the expert on the medicine. What you need is to be a stable, curious presence who can hold whatever the client brings back without either romanticizing it or pathologizing it on sight.
Neutrality here isn't passivity. It's a discipline. Clients can usually tell within a few minutes whether a therapist is going to treat this as fascinating spiritual growth or as evidence of poor judgment, and either reaction shuts down the real work.
Clinical judgment still matters
Curiosity doesn't mean setting aside assessment. A few things worth holding in mind before a client goes, or when they come to you already having gone:
Personal and family history of psychosis or bipolar disorder. These substances can precipitate or worsen manic or psychotic episodes in vulnerable individuals. This is a real risk, not a moralizing talking point, and it deserves a direct conversation.
Current medications. Certain antidepressants, particularly SSRIs and MAOIs, can interact seriously with ayahuasca and other psychedelics. This is a medical question, and clients considering a retreat should be talking to a prescriber, as well as an experienced retreat facilitator, before they go.
Dissociation and complex trauma. These experiences can be profoundly helpful for some trauma survivors and destabilizing for others, sometimes both in the same person. Clients with a strong dissociative pattern may need more scaffolding before and after.
The setting itself. Ask about facilitator training, group size, medical screening on site, and what aftercare was actually offered. We do not need to interrogate the client's choice, but their answers tell you what kind of support they're missing now.
Cardiac and physical health history, especially with kambo and bufo. Both act on the body quickly and directly, through purging or a sharp spike in heart rate and blood pressure. Clients considering either deserve a direct conversation about physical readiness, and whether the facilitator actually screens for cardiac history, not just emotional readiness.
None of this means talking a client out of something they've already decided to do, or already did. It means knowing enough to ask good questions and recognize when something is outside your scope.
A few places to go deeper
MAPS Integration Station (integration.maps.org) — a free integration workbook and a list of practitioners who work with psychedelic integration. MAPS notes they don't vet or endorse anyone listed, so treat it as a starting point, not a referral.
Chacruna Institute (chacruna.net) — an education nonprofit with a strong lens on the cultural and Indigenous roots of plant medicine, useful if you want context beyond the clinical framing.
Psychedelic Support (psychedelic.support) — a directory of therapists and practitioners with training in this area, useful when a client needs more support than you can offer.
Fluence — training for clinicians who want to build real competency in psychedelic-informed therapy and integration, rather than just familiarity.
The bigger shift
This is becoming its own competency, the way trauma-informed care did a generation ago. Clients are going to keep having these experiences whether or not their therapists feel ready for it. The therapists who build real fluency here (not necessarily enthusiasm or alarm, just fluency) are going to be the ones clients trust enough to bring the whole experience to, instead of just the parts that felt safe to mention.
Jennifer, Cap Founder.